GIST-T1 In Vitro Ferric Reducing-antioxidant Power Assay (Oxidative Stress)

This assay is to provide GIST-T1-based In Vitro Ferric Reducing-antioxidant Power Assay (Oxidative Stress) to accelerate our client's oncology projects. The assay will be customized according to the specific requirements. Please contact our scientists to discuss more details.

GIST-T1

Human

A new human cell line, GIST-T1, was established from a metastatic plural tumor from a gastrointestinal stromal tumor (GIST) of the stomach in a Japanese woman, and was characterized by immunohistochemistry, conventional banding methods, comparative genomic hybridization (CGH), and fluorescence in situ hybridization (FISH).

Gastrointestinal Stromal Tumor; GIST

Oncology

In Vitro Ferric Reducing-antioxidant Power Assay (Oxidative Stress)

GIST-T1-cell based In Vitro Ferric Reducing-antioxidant Power Assay (Oxidative Stress)

It's a commonly used simple antioxidant assay. The reduction of a ferric complex to ferrous ions by potential antioxidants is the main principle of the ferric reducing-antioxidant power assay.

Oxidative Stress Assays

Disturbance between the production of reactive oxygen species (ROS), free radicals and antioxidant mechanisms is defined as the oxidative stress, or more precisely, it is an imbalance between the oxidant and antioxidant state in cells. This imbalance can cause harmful effects to cells and biomolecules, which ultimately causes adverse effects in the whole organism. Oxidative imbalance can target important proteinsand lipids in cells, which can increase the risk of developing a cancer. On the other hand, increased ROS production in cancer cells by certain cancer drugs can also arrest cancer cell cycle and cause senescence and apoptosis through oxidative stress.

Antioxidant Assay